US Stock MarketDetailed Quotes

BTMD biote

Watchlist
  • 5.920
  • -0.180-2.95%
Close Jan 7 16:00 ET
  • 5.920
  • 0.0000.00%
Post 16:01 ET
193.58MMarket Cap19.73P/E (TTM)

biote Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

biote Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 53.608M--
--2024/Q4-- / 51.197M--
Nov 12, 20242024/Q351.384M / 51.384M--
Aug 8, 20242024/Q249.169M / 49.062M--
May 7, 20242024/Q146.804M / 45.712M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 53.608M--
--2024/Q4-- / 51.197M--
Nov 12, 20242024/Q351.384M / 51.384M--
Aug 8, 20242024/Q249.169M / 49.062M--
May 7, 20242024/Q146.804M / 45.712M--

Unlock Free Earnings Estimates

biote Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 17:22 ET

  • 8-K: Biote Reports Third Quarter 2024 Financial Results Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages

    Nov 12, 2024 16:26 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 9, 2024 13:57 ET

  • 8-K: Biote Reports Second Quarter 2024 Financial Results Procedure revenue growth accelerates sequentially BioteRx roll-out on track with further expansion planned Management reiterates 2024 financial guidance

    Aug 8, 2024 16:48 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 7, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data